
Design and Applications of Theranostic Nanomedicines
- 1st Edition - September 10, 2022
- Imprint: Woodhead Publishing
- Editors: Somasree Ray, Amit Kumar Nayak
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 8 9 9 5 3 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 8 5 9 8 - 0
Design and Applications of Theranostic Nanomedicines reviews the composition and design of various nanomedicines for theranostic applications, helping readers to make informed… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteDesign and Applications of Theranostic Nanomedicines reviews the composition and design of various nanomedicines for theranostic applications, helping readers to make informed decisions when exploring novel treatments for disease.
This book introduces readers to theranostic nanostructures as nanomedicines, beginning with a balanced look at the associated challenges, costs and benefits. The next section goes on to detail a range of different theranostic nanomedicines and their design, from nanodispersions and nanogels to exosomes and polymeric micelles. A variety of applications is covered, including in the treatment of pulmonary diseases, neurological disorders, cancers and more. The book also takes a look at the toxicological implications of nanotheranostics, an important aspect of any therapy or treatment.
Design and Applications of Theranostic Nanomedicines provides a snapshot of the state-of-the-art, and will be of use to materials scientists, biomedical engineers and pharmaceutical scientists with an interest in nanotechnology and theranostics.
- Explores the challenges, costs, benefits and toxicological implications of nanotheranostics
- Reviews a range of nanomedicines and their design, including liposomes, nanohydrogels, nanocochleate and more
- Details a variety of applications, such as in drug delivery, neurological disorders, cardiovascular diseases and so on
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- Preface
- Section I. Introduction
- 1. Theranostic nanostructures as nanomedicines: benefits, costs, and future challenges
- 1.1. Introduction
- 1.2. Nanotechnology, nanoscale, and nanostructures
- 1.3. Design of theranostic nanostructures as nanomedicines
- 1.4. Applications of theranostic nanostructures as nanomedicines
- 1.5. Benefits and costs of theranostic nanostructures as nanomedicines
- 1.6. Challenges of theranostic nanostructures as nanomedicines
- 1.7. Conclusion
- Section II. Design
- 2. Theranostic nanogels: design and applications
- 2.1. Introduction
- 2.2. Nanogels
- 2.3. Theranostic nanogels
- 2.4. Designs of theranostic nanogels
- 2.5. Conclusion
- 3. Exosomes: a novel tool for diagnosis and therapy
- 3.1. Introduction
- 3.2. Exosomes
- 3.3. Biological functions of exosomes
- 3.4. Exosomes as biomarkers of diseases
- 3.5. Exosomes as therapeutic tools in other pathologies
- 3.6. Exosomes as a novel tool for diagnosis
- 4. Engineered liposomes as drug delivery and imaging agents
- 4.1. Introduction
- 4.2. Liposomes and their classifications
- 4.3. Preparation of liposomes
- 4.4. Rationale for the development of engineered liposomes
- 4.5. Engineered liposomes in drug delivery
- 4.6. Engineered liposomes in imaging
- 4.7. Theranostic engineered liposomes
- 4.8. Challenges and limitations of engineered liposomes as nanotheranostics
- 4.9. Conclusion and future perspective
- 5. Polymeric micelles for theranostic uses
- 5.1. Introduction
- 5.2. Advantages and disadvantages of polymeric micelle
- 5.3. Different types of polymer micelle as carrier systems used for the delivery of drugs
- 5.4. Mechanism of drug release from polymeric micelles
- 5.5. Pharmaceutical applications of polymeric micelle
- 5.6. Conclusion
- 6. Dendrimers: an effective drug delivery and therapeutic approach
- 6.1. Introduction
- 6.2. Synthesis procedure of dendrimer structure
- 6.3. Dendrimers in drug delivery
- 6.4. Advancement of dendrimer-based drug delivery in biomedical field
- 6.5. Conclusion
- 7. Nanocochleates: A novel lipid-based nanocarrier system for drug delivery
- 7.1. Introduction
- 7.2. History of the development of nanocochleates
- 7.3. Chemistry and mechanism of self-assembly of nanocochleates
- 7.4. Components of nanocochleates
- 7.5. Routes of administration
- 7.6. Advantages of nanocochleate-based drug delivery system
- 7.7. Limitations of nanocochleate-based drug delivery system
- 7.8. Mechanism of action of nanocochleate-based drug delivery system
- 7.9. Method of nanocochleates preparation
- 7.10. Stabilization of nanocochleates
- 7.11. Characterization of nanocochleates
- 7.12. Applications of nanocochleate-based drug delivery system
- 7.13. Commercial status of nanocochleates
- 7.14. Conclusions and future perspectives
- Section III. Applications
- 8. Theranostic applications of nanoemulsions in pulmonary diseases
- 8.1. Introduction
- 8.2. Theranostic applications of NEs
- 8.3. NEs-based drug delivery systems
- 8.4. NEs-based diagnostics
- 8.5. Clearance of NEs
- 8.6. Advantages and disadvantages of NEs
- 8.7. Conclusion
- 9. Polymeric nanoparticles as tumor-targeting theranostic platform
- 9.1. Introduction
- 9.2. Definition of nanothranostics with some examples
- 9.3. Significance of nanotheranostic and comparison between nanotheranostic and nanotherapeutics
- 9.4. Advantages of polymeric nanoparticles for tumor targeting
- 9.5. Nanoparticles for imaging, diagnosis, and therapy
- 9.6. Different methods of tumor targeting
- 9.7. Polymeric nanomedicines in a clinical trial
- 9.8. Future prospect
- 9.9. Conclusion
- 10. Site-specific theranostic uses of stimuli responsive nanohydrogels
- 10.1. Introduction
- 10.2. Classification of nano hydrogel
- 10.3. Stimulus responsive nanogels
- 10.4. Applications of nanogels in drug delivery
- 10.5. Toxicity of stimulus sensitive nanogels
- 10.6. Conclusion
- 11. Ligand appended theranostic nanocarriers for targeted blood–brain barrier
- 11.1. Introduction
- 11.2. Blood–brain barrier
- 11.3. Ligand appended nanocarriers
- 11.4. Applications of ligand appended nanocarriers
- 11.5. Underlying challenges and future prospects
- 12. Nanotheranostics in CNS Malignancy
- 12.1. Introduction
- 12.2. Glioblastoma
- 12.3. Blood brain barrier (BBB)
- 12.4. Blood brain tumor barrier (BBTB)
- 12.5. Nanotheranostics
- 12.6. Conclusion
- 13. Application of nanotheranostics in cancer
- 13.1. Introduction
- 13.2. Nanomedicines as cancer theranostics
- 13.3. Emergence and scope of nanotheranostics
- 13.4. Conclusion
- 14. Self-assembled protein nanoparticles for multifunctional theranostic uses
- 14.1. Introduction
- Section IV. Others
- 15. Nanotheranostics: The toxicological implications
- 15.1. Nanotheranostics: A tool for personifying medicine
- 15.2. Nanotheranostics: Bridging a therapeutic notch
- 15.3. Toxicity in nanotheranostics
- 15.4. Hazards associated with nanotheranostics
- 15.5. Factors influencing toxic responses to nanotheranostic agents
- 15.6. Toxic concern of materials commonly used in nanotheranostics
- 15.7. Silica
- 15.8. Toxicity in nanotheranostics: the mechanistic basis
- 15.9. Toxicity evaluation of nanotheranostic agents: testing systems in vitro and in vivo
- 15.10. Conclusion
- Index
- Edition: 1
- Published: September 10, 2022
- Imprint: Woodhead Publishing
- No. of pages: 434
- Language: English
- Paperback ISBN: 9780323899536
- eBook ISBN: 9780323885980
SR
Somasree Ray
AN
Amit Kumar Nayak
Dr. Amit Kumar Nayak (MPharm, PhD) is working as a professor, at the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O' Anusandhan (Deemed to be University), Odisha, India. He has earned his PhD from IFTM University, Moradabad, Uttar Pradesh, India. He has over 14 years of research experiences in the field of pharmaceutics, especially in the development and characterization of novel biopolymeric and nanostructured drug delivery systems. Till date, he has authored more than 138 research and review publications in various high-impact peer-reviewed journals and 135 book chapters. He has edited/authored 23 international books to his credit. Dr. Nayak has presented his research work at several conferences. He has received University Foundation Day Research Award, 2019 and 2022 by Biju Patnaik University of Technology, Odisha. Dr. Nayak is a life member of the Association of Pharmaceutical Teachers of India (APTI) and a registered pharmacist.